198 related articles for article (PubMed ID: 38125741)
1. C‑reactive protein and related predictors in soft tissue sarcoma (Review).
Nakamura T; Asanuma K; Hagi T; Sudo A
Mol Clin Oncol; 2024 Jan; 20(1):6. PubMed ID: 38125741
[TBL] [Abstract][Full Text] [Related]
2. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Samonigg H; Maurer-Ertl W; Stojakovic T; Ploner F; Leithner A; Pichler M
Br J Cancer; 2013 Oct; 109(9):2316-22. PubMed ID: 24084772
[TBL] [Abstract][Full Text] [Related]
3. Role of high‑sensitivity C‑reactive protein in patients with sarcoma.
Aggerholm-Pedersen N; Baad-Hansen T; Møller HJ; Sandfeld-Paulsen B
Oncol Lett; 2023 Dec; 26(6):531. PubMed ID: 38020307
[TBL] [Abstract][Full Text] [Related]
4. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative serum interleukin-6 level is predictive for worse postoperative outcome after soft tissue sarcoma surgery.
van der Laan P; van der Graaf WTA; Reijers SJM; Schrage YM; Hendriks JJH; Haas RL; van den Broek D; Steeghs N; van Houdt WJ
Eur J Surg Oncol; 2023 Sep; 49(9):106926. PubMed ID: 37173151
[TBL] [Abstract][Full Text] [Related]
8. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas.
Hagi T; Nakamura T; Iino T; Matsubara T; Asanuma K; Matsumine A; Sudo A
Sci Rep; 2017 Aug; 7(1):9640. PubMed ID: 28851899
[TBL] [Abstract][Full Text] [Related]
10. Role of high-sensitivity C-reactive protein in the differentiation of benign and malignant soft tissue tumors.
Nakamura T; Matsumine A; Iino T; Matsubara T; Asanuma K; Uchida A; Sudo A
Anticancer Res; 2014 Feb; 34(2):933-6. PubMed ID: 24511035
[TBL] [Abstract][Full Text] [Related]
11. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
[TBL] [Abstract][Full Text] [Related]
12. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
[TBL] [Abstract][Full Text] [Related]
13. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.
Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L
Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786
[TBL] [Abstract][Full Text] [Related]
14. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
Wang X; Liu S; Zhao X; Fang E; Zhao X
PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
[TBL] [Abstract][Full Text] [Related]
15. Is Serum Lactate Dehydrogenase Useful for Predicting Oncological Outcome in Patients With Soft Tissue Sarcoma?
Nakamura T; Asanuma K; Hagi T; Sudo A
Anticancer Res; 2019 Dec; 39(12):6871-6875. PubMed ID: 31810955
[TBL] [Abstract][Full Text] [Related]
16. Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?
Nakamura T; Hagi T; Asanuma K; Sudo A
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358634
[TBL] [Abstract][Full Text] [Related]
17. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma.
Matsui Y; Matsuda A; Maejima A; Shinoda Y; Nakamura E; Komiyama M; Fujimoto H
Int J Clin Oncol; 2022 Jun; 27(6):1093-1100. PubMed ID: 35319075
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.
Nakamura T; Katagiri H; Shido Y; Hamada S; Yamada K; Nagano A; Yamada S; Tsukushi S; Ishimura D; Matsumine A; Sudo A; Nishida Y
Anticancer Res; 2017 Jun; 37(6):3137-3141. PubMed ID: 28551655
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
